Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis

Author(s): Scarpellini E., Lupo M., Iegri C., Gasbarrini A., De Santis A. and Tack J.

Volume 9 , Issue 3 , 2014

Page: [141 - 147] Pages: 7

DOI: 10.2174/1574887109666141216104334

Price: $65

Abstract

The gut-liver axis model has helped to explain the liver steatosis (NAFLD) and steatohepatitis (NASH) etiopathogenesis. The discovery of a key role for an altered intestinal permeability (IP) in this pathophysioligcal framework has closed the link between gut lumen antigenic/toxic substances and systemic and liver inflammation in NAFLD and obesity, metabolic syndrome. Recent evidence from the literature show how IP can be modulated by several non-pharmacological and pharmacological agents and be the target for future preventive and curative treatment of NAFLD and NASH.

In this review we describe the concept of IP, its ultrastructural basis, its role in the NALFD pathophysiology and emerging evidence on non-pharmacological and pharmacological agents able to favourably modulate it.

Keywords: Intestinal permeability, zonulin-1, claudin, nafld, nash, lipopolysaccharide.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy